STADA: Nizhpharm acquisition successfully concluded
01/25/2005 . Press Release
STADA Arzneimittel AG has successfully acquired 97.47% of the shares of the Russian pharmaceutical company Nizhpharm OJSC, Nizhny Novgorod, after the Russian anti-trust authorities approved the transaction and all contractual agreements had been implemented (see ad hoc release dated November 8, 2004 concerning the conclusion of the provisional agreement, published by DGAP, as well as ad hoc release dated December 22, 2004 concerning the conclusion of final agreements, published by DGAP).
Nizhpharm will be included in the scope of consolidation of the STADA Group as of January 1, 2005.
For more information, please contact:
STADA Arzneimittel AG
D-61118 Bad Vilbel
Tel.: +49 6101 603-113
Fax: +49 6101 603-506